170 related articles for article (PubMed ID: 27598026)
21. Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.
Momany MC; Martinez-Gutierrez J; Soto M; Capurro D; Ciampi F; Thompson B; Puschel K
BMC Cancer; 2017 Dec; 17(1):847. PubMed ID: 29237420
[TBL] [Abstract][Full Text] [Related]
22. Developing a hand-held Pap test card to improve cervical cancer screening.
Prendergast MB; Hunter LP
Nurs Womens Health; 2014; 18(3):212-9. PubMed ID: 24939198
[TBL] [Abstract][Full Text] [Related]
23. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
24. Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results.
Miyagi E; Sukegawa A; Motoki Y; Kaneko T; Maruyama Y; Asai-Sato M; Numazaki R; Mizushima S; Hirahara F
J Obstet Gynaecol Res; 2014 Apr; 40(4):1105-13. PubMed ID: 24428631
[TBL] [Abstract][Full Text] [Related]
25. Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas.
Thompson B; Carosso EA; Jhingan E; Wang L; Holte SE; Byrd TL; Benavides MC; Lopez C; Martinez-Gutierrez J; Ibarra G; Gonzalez VJ; Gonzalez NE; Duggan CR
Cancer; 2017 Feb; 123(4):666-674. PubMed ID: 27787893
[TBL] [Abstract][Full Text] [Related]
26. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.
Sewali B; Okuyemi KS; Askhir A; Belinson J; Vogel RI; Joseph A; Ghebre RG
Cancer Med; 2015 Apr; 4(4):620-31. PubMed ID: 25653188
[TBL] [Abstract][Full Text] [Related]
28. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
29. Violence against women increases cancer diagnoses: Results from a meta-analytic review.
Reingle Gonzalez JM; Jetelina KK; Olague S; Wondrack JG
Prev Med; 2018 Sep; 114():168-179. PubMed ID: 29981792
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
31. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
32. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis.
Tseng DS; Cox E; Plane MB; Hla KM
J Gen Intern Med; 2001 Aug; 16(8):563-8. PubMed ID: 11556935
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer screening among women without a cervix.
Sirovich BE; Welch HG
JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
[TBL] [Abstract][Full Text] [Related]
35. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer screening after 50: near extinction?
Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
[TBL] [Abstract][Full Text] [Related]
37. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
[TBL] [Abstract][Full Text] [Related]
38. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
39. Easy screening for everyone.
Palazzi M; Severi M; Imolesi C; Vitali P; Farneti M; Bianchini A; Cristallo T
Epidemiol Prev; 2016; 40(3-4):179-84. PubMed ID: 27436251
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
